CIK 0001783183
- Non-accelerated filer
- Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 824151574
- Phone
- +1 877-742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 4 Open-market sale 10% owner sold 710,000 shares at $43.75 ($31,062,500)
- 4 Open-market sale Director sold 55,000 shares at an average $47.58 ($2,617,090)
- 4 Open-market sale Chief Operating Officer sold 14,500 shares at an average $45.88 ($665,290)
- 4 Open-market sale Director sold 70,000 shares at an average $46.49 ($3,254,612)
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale Chief Operating Officer sold 14,500 shares at an average $39.89 ($578,441)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 40,000 shares at an average $35.70 ($1,428,038)
- 4 Open-market sale Chief Operating Officer sold 14,500 shares at an average $33.61 ($487,275)
- 4 Open-market sale Director sold 79,658 shares at an average $43.42 ($3,458,896)
- 4 Open-market sale Chief Operating Officer sold 14,500 shares at an average $44.74 ($648,688)
- 4 Open-market sale Director sold 30,342 shares at an average $41.30 ($1,253,198)
- 4 Open-market sale Chief Operating Officer sold 14,500 shares at $36.83 ($534,026)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition 10% owner disposed of 1,456,854 shares (other)
Page 10 of 12 · 224 filings